Catherine M. Tangen
Fred Hutch Cancer Center · 523 works · 64,970 citations · h-index 82
Top works
- Frailty in Older Adults: Evidence for a Phenotype
- Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
- The Influence of Finasteride on the Development of Prostate Cancer
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
- Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
- Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer
- A Southwest Oncology Group study
- Vitamin E and the Risk of Prostate Cancer
- Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
- Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
- Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
- Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)